Torcetrapib |
A CETP inhibitor (IC50s = 47 and 51 nM for cholesteryl and triglyceride tr… |
5 mg |
15028-5 |
More Info
|
Torcetrapib |
A CETP inhibitor (IC50s = 47 and 51 nM for cholesteryl and triglyceride tr… |
50 mg |
15028-50 |
More Info
|
Toremifene (citrate) |
A SERM that evokes tissue-dependent effects similar to that of tamoxifen |
100 mg |
20854-100 |
More Info
|
Toremifene (citrate) |
A SERM that evokes tissue-dependent effects similar to that of tamoxifen |
250 mg |
20854-250 |
More Info
|
Toremifene (citrate) |
A SERM that evokes tissue-dependent effects similar to that of tamoxifen |
50 mg |
20854-50 |
More Info
|
Toremifene (citrate) |
A SERM that evokes tissue-dependent effects similar to that of tamoxifen |
500 mg |
20854-500 |
More Info
|
Toremifene-d6 |
An internal standard for the quantification of toremifene by GC- or LC-MS |
1 mg |
30728-1 |
More Info
|
Torin 1 |
A potent and selective inhibitor of mTOR (IC50 = 2 and 10 nM for mTORC1 an… |
10 mg |
10997-10 |
More Info
|
Torin 1 |
A potent and selective inhibitor of mTOR (IC50 = 2 and 10 nM for mTORC1 an… |
25 mg |
10997-25 |
More Info
|
Torin 1 |
A potent and selective inhibitor of mTOR (IC50 = 2 and 10 nM for mTORC1 an… |
50 mg |
10997-50 |
More Info
|
Torin 2 |
An potent, selective inhibitor of cellular mTOR activity (EC50 = 0.3 nM) w… |
10 mg |
14185-10 |
More Info
|
Torin 2 |
An potent, selective inhibitor of cellular mTOR activity (EC50 = 0.3 nM) w… |
25 mg |
14185-25 |
More Info
|
Torin 2 |
An potent, selective inhibitor of cellular mTOR activity (EC50 = 0.3 nM) w… |
5 mg |
14185-5 |
More Info
|
Tormentic Acid |
A triterpene with diverse biological activities; reduces hydrogen peroxide… |
1 mg |
30696-1 |
More Info
|
Tormentic Acid |
A triterpene with diverse biological activities; reduces hydrogen peroxide… |
10 mg |
30696-10 |
More Info
|
Tormentic Acid |
A triterpene with diverse biological activities; reduces hydrogen peroxide… |
5 mg |
30696-5 |
More Info
|
Tosedostat |
An aminopeptidase inhibitor (IC50s = 100, 150, and 220 nM for LAP, PUSA, a… |
1 mg |
23395-1 |
More Info
|
Tosedostat |
An aminopeptidase inhibitor (IC50s = 100, 150, and 220 nM for LAP, PUSA, a… |
5 mg |
23395-5 |
More Info
|
Tosufloxacin (tosylate) |
A fluoroquinolone antibiotic |
1 g |
21427-1 |
More Info
|
Tosufloxacin (tosylate) |
A fluoroquinolone antibiotic |
100 mg |
21427-100 |
More Info
|
Tosufloxacin (tosylate) |
A fluoroquinolone antibiotic |
250 mg |
21427-250 |
More Info
|
Tosufloxacin (tosylate) |
A fluoroquinolone antibiotic |
500 mg |
21427-500 |
More Info
|
Tosyllysine Chloromethyl Ketone (hydrochloride) |
An active site-directed agent that inhibits serine proteinases with trypsi… |
100 mg |
13074-100 |
More Info
|
Tosyllysine Chloromethyl Ketone (hydrochloride) |
An active site-directed agent that inhibits serine proteinases with trypsi… |
250 mg |
13074-250 |
More Info
|
Tosyllysine Chloromethyl Ketone (hydrochloride) |
An active site-directed agent that inhibits serine proteinases with trypsi… |
50 mg |
13074-50 |
More Info
|
Tosyl Phenylalanyl Chloromethyl Ketone |
An irreversible inhibitor of chymotrypsin-like proteases that has been sho… |
1 g |
20166-1 |
More Info
|
Tosyl Phenylalanyl Chloromethyl Ketone |
An irreversible inhibitor of chymotrypsin-like proteases that has been sho… |
100 mg |
20166-100 |
More Info
|
Tosyl Phenylalanyl Chloromethyl Ketone |
An irreversible inhibitor of chymotrypsin-like proteases that has been sho… |
250 mg |
20166-250 |
More Info
|
Tosyl Phenylalanyl Chloromethyl Ketone |
An irreversible inhibitor of chymotrypsin-like proteases that has been sho… |
500 mg |
20166-500 |
More Info
|
Total and Direct Bilirubin Colorimetric Assay Kit |
Cayman's Total and Direct Bilirubin Colorimetric Assay provides a rapid, r… |
1 ea |
701720-1EA |
More Info
|
Total Collagen/Hydroxyproline Assay Kit |
Cayman's Total Collagen / Hydroxyproline Assay Kit provides colorimetric-b… |
96 Well |
702440-96WELLS |
More Info
|
Total Iron-Binding Capacity (TIBC) and Serum Iron Assay Kit |
Cayman's Total Iron-Binding Capacity (TIBC) and Serum Iron Assay Kit provi… |
1 ea |
702230-1EA |
More Info
|
Totarol |
A diterpene with diverse biological activities; active against Gram-positi… |
100 mg |
26412-100 |
More Info
|
Totarol |
A diterpene with diverse biological activities; active against Gram-positi… |
250 mg |
26412-250 |
More Info
|
Totarol |
A diterpene with diverse biological activities; active against Gram-positi… |
50 mg |
26412-50 |
More Info
|
Totarol |
A diterpene with diverse biological activities; active against Gram-positi… |
500 mg |
26412-500 |
More Info
|
Toxin A from Clostridium difficile |
An enterotoxin that inactivates host Rho family GTPases by glucosylation,… |
100 µg |
19664-100 |
More Info
|
Toxin B from Clostridium difficile |
A cytotoxin that inactivates host Rho family GTPases by glucosylation, alt… |
50 µg |
19665-50 |
More Info
|
Toyocamycin (hydrate) |
A natural adenosine analog that prevents IRE1α-induced mRNA cleavage… |
1 mg |
17371-1 |
More Info
|
Toyocamycin (hydrate) |
A natural adenosine analog that prevents IRE1α-induced mRNA cleavage… |
10 mg |
17371-10 |
More Info
|
Toyocamycin (hydrate) |
A natural adenosine analog that prevents IRE1α-induced mRNA cleavage… |
25 mg |
17371-25 |
More Info
|
Toyocamycin (hydrate) |
A natural adenosine analog that prevents IRE1α-induced mRNA cleavage… |
5 mg |
17371-5 |
More Info
|
Tozadenant |
An adenosine A2A receptor antagonist (Kis = 11.5 and 6 nM for human and rh… |
10 mg |
28452-10 |
More Info
|
Tozadenant |
An adenosine A2A receptor antagonist (Kis = 11.5 and 6 nM for human and rh… |
100 mg |
28452-100 |
More Info
|
Tozadenant |
An adenosine A2A receptor antagonist (Kis = 11.5 and 6 nM for human and rh… |
25 mg |
28452-25 |
More Info
|
Tozadenant |
An adenosine A2A receptor antagonist (Kis = 11.5 and 6 nM for human and rh… |
50 mg |
28452-50 |
More Info
|
TP-0463518 |
A pan HIF-PH inhibitor; inhibits human HIF-PH1 (Ki = 5.3 nM), as well as h… |
10 mg |
33788-10 |
More Info
|
TP-0463518 |
A pan HIF-PH inhibitor; inhibits human HIF-PH1 (Ki = 5.3 nM), as well as h… |
25 mg |
33788-25 |
More Info
|
TP-0463518 |
A pan HIF-PH inhibitor; inhibits human HIF-PH1 (Ki = 5.3 nM), as well as h… |
5 mg |
33788-5 |
More Info
|
TP-0463518 |
A pan HIF-PH inhibitor; inhibits human HIF-PH1 (Ki = 5.3 nM), as well as h… |
50 mg |
33788-50 |
More Info
|
TP-064 |
A potent inhibitor of PRMT4 (IC50 50 = 43 nM) in vitro, |
1 mg |
20256-1 |
More Info
|
TP-064 |
A potent inhibitor of PRMT4 (IC50 50 = 43 nM) in vitro, |
10 mg |
20256-10 |
More Info
|
TP-064 |
A potent inhibitor of PRMT4 (IC50 50 = 43 nM) in vitro, |
25 mg |
20256-25 |
More Info
|
TP-064 |
A potent inhibitor of PRMT4 (IC50 50 = 43 nM) in vitro, |
5 mg |
20256-5 |
More Info
|
TP-0903 |
An inhibitor of Axl (IC50 = 27 nM ); exhibits greater than 50% inhibition… |
1 mg |
28757-1 |
More Info
|
TP-0903 |
An inhibitor of Axl (IC50 = 27 nM ); exhibits greater than 50% inhibition… |
10 mg |
28757-10 |
More Info
|
TP-0903 |
An inhibitor of Axl (IC50 = 27 nM ); exhibits greater than 50% inhibition… |
25 mg |
28757-25 |
More Info
|
TP-0903 |
An inhibitor of Axl (IC50 = 27 nM ); exhibits greater than 50% inhibition… |
5 mg |
28757-5 |
More Info
|
TP-3654 |
A Pim kinase inhibitor (Kis = 5, 239, and 42 nM for Pim-1, Pim-2, and Pim-… |
10 mg |
29571-10 |
More Info
|
TP-3654 |
A Pim kinase inhibitor (Kis = 5, 239, and 42 nM for Pim-1, Pim-2, and Pim-… |
25 mg |
29571-25 |
More Info
|
TP-3654 |
A Pim kinase inhibitor (Kis = 5, 239, and 42 nM for Pim-1, Pim-2, and Pim-… |
5 mg |
29571-5 |
More Info
|
TP-472 |
A BRD9 inhibitor (Kd = 33 nM; EC50 = 320 nM in a NanoBRET assay); >30-fold… |
1 mg |
20030-1 |
More Info
|
TP-472 |
A BRD9 inhibitor (Kd = 33 nM; EC50 = 320 nM in a NanoBRET assay); >30-fold… |
5 mg |
20030-5 |
More Info
|
TP-4748 |
A heterocyclic building block; has been used in the synthesis of prolyl-tR… |
10 mg |
31459-10 |
More Info
|
TP-4748 |
A heterocyclic building block; has been used in the synthesis of prolyl-tR… |
25 mg |
31459-25 |
More Info
|
TP-4748 |
A heterocyclic building block; has been used in the synthesis of prolyl-tR… |
50 mg |
31459-50 |
More Info
|
TP-808 |
An intermediate in the synthesis of synthetic tetracycline antibiotics, |
100 mg |
24181-100 |
More Info
|
TP-808 |
An intermediate in the synthesis of synthetic tetracycline antibiotics, |
250 mg |
24181-250 |
More Info
|
TP-808 |
An intermediate in the synthesis of synthetic tetracycline antibiotics, |
50 mg |
24181-50 |
More Info
|
TP-060 |
An inhibitor of UDP-glucose ceramide glucosyltransferase (IC50 = 0.031 &mi… |
1 mg |
41127-1 |
More Info
|
TP-060 |
An inhibitor of UDP-glucose ceramide glucosyltransferase (IC50 = 0.031 &mi… |
5 mg |
41127-5 |
More Info
|
TP53BP1 BRCT domains (human, recombinant) |
Source: Recombinant human N-terminal GST-tagged protein expressed in E. co… |
100 µg |
14171-100 |
More Info
|
TP53BP1 BRCT domains (human, recombinant) |
Source: Recombinant human N-terminal GST-tagged protein expressed in E. co… |
25 µg |
14171-25 |
More Info
|
TP53BP1 BRCT domains (human, recombinant) |
Source: Recombinant human N-terminal GST-tagged protein expressed in E. co… |
50 µg |
14171-50 |
More Info
|
TP53BP1 tudor-like region (human recombinant) |
Source: Recombinant N-terminal GST-tagged protein expressed in E. coli &bu… |
100 µg |
14073-100 |
More Info
|